Terms: = Liver cancer AND FOXP1, MGC12942, 27086, ENSG00000114861, hFKH1B, MGC99551, FLJ23741, QRF1, 12CC4, HSPC215, MGC88572 AND Treatment
7 results:
1. Identification of foxp1 as a favorable prognostic biomarker and tumor suppressor in intrahepatic cholangiocarcinoma.
Tang C; Zhuang H; Tong H; Yu X; Chen J; Wang Q; Ma X; Wang B; Hua Y; Shang C; Tang Z
BMC Cancer; 2024 Jan; 24(1):137. PubMed ID: 38279090
[TBL] [Abstract] [Full Text] [Related]
2. Impact of foxp1 rs2687201 genetic variant on the susceptibility to HCV-related hepatocellular carcinoma in Egyptians.
Motawi TMK; Sabry D; Shehata NI; William MM; Fahim AT
J Biochem Mol Toxicol; 2022 Mar; 36(3):e22965. PubMed ID: 34783112
[TBL] [Abstract] [Full Text] [Related]
3. Circular RNA foxp1 promotes tumor progression and Warburg effect in gallbladder cancer by regulating PKLR expression.
Wang S; Zhang Y; Cai Q; Ma M; Jin LY; Weng M; Zhou D; Tang Z; Wang JD; Quan Z
Mol Cancer; 2019 Oct; 18(1):145. PubMed ID: 31623628
[TBL] [Abstract] [Full Text] [Related]
4. [Depletion of GP73 inhibits invasion and metastasis of hepatocellular carcinoma cells].
Liu LP; Chen JK; Liu YM; Zhang DH; Zhang J; Yang XL
Zhonghua Zhong Liu Za Zhi; 2017 Jul; 39(7):497-501. PubMed ID: 28728294
[No Abstract] [Full Text] [Related]
5. foxp1 and SPINK1 reflect the risk of cirrhosis progression to HCC with HBV infection.
Li F; Liu T; Xiao CY; Yu JX; Lu LG; Xu MY
Biomed Pharmacother; 2015 May; 72():103-8. PubMed ID: 26054682
[TBL] [Abstract] [Full Text] [Related]
6. Mixed adenoneuroendocrine carcinoma of the colon: molecular pathogenesis and treatment.
Vanacker L; Smeets D; Hoorens A; Teugels E; Algaba R; Dehou MF; De Becker A; Lambrechts D; De Greve J
Anticancer Res; 2014 Oct; 34(10):5517-21. PubMed ID: 25275049
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic significance of foxp1 as an oncogene in hepatocellular carcinoma.
Zhang Y; Zhang S; Wang X; Liu J; Yang L; He S; Chen L; Huang J
J Clin Pathol; 2012 Jun; 65(6):528-33. PubMed ID: 22422806
[TBL] [Abstract] [Full Text] [Related]
